Patient Pathfinder: Clinical Trials
Clinical Trials for Myeloproliferative Neoplasms
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myeloproliferative Neoplasms (MPNs), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 119 active Myeloproliferative Neoplasms trials
A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)
Study Type: Interventional Phase 3
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Study Type: Observational
A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis
Study Type: Interventional Phase 1
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Study Type: Interventional Phase 2
Asciminib Roll-over Study
Study Type: Interventional Phase 3
Study to Assess SLN124 in Patients With Polycythemia Vera
Study Type: Interventional Phase 1
A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET
Study Type: Interventional Phase 2
A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV
Study Type: Interventional Phase 3
There are 119 active Myeloproliferative Neoplasms trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now